There is evidence that genetic testing soon after ovarian cancer diagnosis does not add to the negative psychological response caused by the cancer diagnosis itself, but that finding out about BRCA1/BRCA2 carrier status may lead to a slight increase in the psychological burden at that time (Plaskocinska et al. 2016). Here, BRCA2 is linked to ovarian carcinoma.